NCT01675856

Brief Summary

Acute upper gastrointestinal bleeding (UGIB) is one of the commonest medical emergencies. The condition accounts for 150 per 100,000 populations. A National United Kingdom reported a crude overall mortality rate of 10%. While bleeding stops spontaneously in majority of patients at their presentation, there remains a subgroup of patients who continue to bleed or develop recurrent bleeding. In these patients, the mortality increases manifolds. If these high-risk patients can be identified, early interventions may improve their outcomes. Several prognostic indices are in use for the purpose of patient stratification. They include the Rockall, Glasgow-Blatchford (GBS) and the Baylor scores. The Rockall score is a composite score which incorporates clinical parameters as well as findings during endoscopy which was derived to predict mortality. The GBS is a pre-endoscopy or a clinical score for the prediction for the need of further intervention loosely defined as the need for transfusion, endoscopy or surgery. It has been shown to be accurate in identifying low risk patients for early discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
516

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 27, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 30, 2012

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2018

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

6.3 years

First QC Date

August 27, 2012

Last Update Submit

January 31, 2019

Conditions

Keywords

Glasgow-Blatchford scoreGastrointestinal bleeding

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Death from all causes 30 days from randomization

    30 days

Secondary Outcomes (9)

  • Need for endoscopic therapy at index endoscopy

    At the time of index endoscopy

  • Need for transfusion

    Within 30days of randomization

  • Recurrent bleeding as defined

    Within 30days of randomization

  • Duration of hospital stay of index bleeding

    Within 30 days of randomization

  • ICU stay

    Within 30days of randomization

  • +4 more secondary outcomes

Study Arms (2)

Urgent endoscopy

ACTIVE COMPARATOR

Oesophagogastroduodenoscopy done within 6hours of first GI specialists consultation

Other: Urgent endoscopy

Early endoscopy

PLACEBO COMPARATOR

Oesophagogastroduodenoscopy done within 24hours of first GI specialists consultation

Other: Early endoscopy

Interventions

Defined by oesophagogastroduodenoscopy within 6 hours of first presentation of Prince of Wales Hospital

Urgent endoscopy

Defined by oesophagogastroduodenoscopy within 24 hours of first presentation of Prince of Wales Hospital

Early endoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Overt signs of upper gastrointestinal bleeding (i.e., melena or hematemesis with or without hypotension)
  • GBS of ≥12
  • In-patients admitted for reasons other than AUGIB who develop bleeding are also considered for trial enrollment.
  • Patients in Hypotensive shock (SBP ≤90 mmHg or pulse ≥110 bpm) are initially resuscitated and then considered for trial entry if their condition can be stabilized.

You may not qualify if:

  • continued shock despite initial volume resuscitation (refractory shock) undergo urgent endoscopy
  • \< 18 years of age
  • Unable to provide written informed consent
  • Pregnant or lactating women
  • Moribund patients from terminal illnesses. (active treatment not considered)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endoscopy Centre, Prince of Wales Hospital

Hong Kong, China

Location

Related Publications (1)

  • Lau JYW, Yu Y, Tang RSY, Chan HCH, Yip HC, Chan SM, Luk SWY, Wong SH, Lau LHS, Lui RN, Chan TT, Mak JWY, Chan FKL, Sung JJY. Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding. N Engl J Med. 2020 Apr 2;382(14):1299-1308. doi: 10.1056/NEJMoa1912484.

MeSH Terms

Conditions

Peptic Ulcer HemorrhageGastrointestinal Hemorrhage

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • James Y LAU, MD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients are randomized in a 1:1 ratio. The patient is randomized to receive; 1. Urgent endoscopy (defined by endoscopy within 6 hours from first consultation by GI specialists at PWH) or 2. Early endoscopy (defined by endoscopy next morning and within 24 hours from first consultation by GI specialists at PWH)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 27, 2012

First Posted

August 30, 2012

Study Start

July 28, 2012

Primary Completion

November 11, 2018

Study Completion

November 11, 2018

Last Updated

February 1, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations